{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:54:09Z","timestamp":1781931249382,"version":"3.54.5"},"reference-count":83,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2016.00108","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T03:17:12Z","timestamp":1462159032000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":68,"title":["Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention"],"prefix":"10.3389","volume":"6","author":[{"given":"Sophia H. L.","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Slomovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,5,2]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fonc.2014.00005","article-title":"BRCA and early events in the development of serous ovarian cancer","volume":"4","author":"George","year":"2014","journal-title":"Front Oncol"},{"issue":"3","key":"B3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ygyno.2015.06.017","article-title":"Why have ovarian cancer mortality rates declined? Part I. Incidence","volume":"138","author":"Sopik","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"Suppl 2","key":"B4","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/j.ijgo.2015.06.007","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"131","author":"Berek","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"B5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/00016340500324621","article-title":"Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention","volume":"85","author":"Sogaard","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"B6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"9055","key":"B7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(05)61782-5","article-title":"Ovarian cancer risk and family history","volume":"349","author":"Foulkes","year":"1997","journal-title":"Lancet"},{"issue":"5645","key":"B8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"issue":"1","key":"B9","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"1","key":"B10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/cge.12132","article-title":"The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas","volume":"85","author":"Akbari","year":"2014","journal-title":"Clin Genet"},{"issue":"2","key":"B11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10549-010-1156-9","article-title":"A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas","volume":"125","author":"Donenberg","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"44","key":"B12","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"B13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"issue":"1","key":"B14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ygyno.2012.12.016","article-title":"Global ovarian cancer health disparities","volume":"129","author":"Chornokur","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"4","key":"B15","first-page":"292","article-title":"Incessant ovulation and ovarian cancer \u2013 a hypothesis re-visited","volume":"5","author":"Fathalla","year":"2013","journal-title":"Facts Views Vis Obgyn"},{"issue":"12","key":"B16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.7326\/0003-4819-157-11-201212040-00539","article-title":"Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"11","key":"B17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"B18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"issue":"7716","key":"B19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation \u2013 a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"issue":"12","key":"B20","doi-asserted-by":"publisher","first-page":"e8534","DOI":"10.1371\/journal.pone.0008534","article-title":"Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas","volume":"4","author":"Clark-Knowles","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"B21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"B22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"issue":"18","key":"B23","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"B24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/path.2927","article-title":"Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers","volume":"225","author":"George","year":"2011","journal-title":"J Pathol"},{"issue":"13","key":"B25","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-07-4959","article-title":"Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma","volume":"14","author":"Tone","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"16","key":"B26","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1158\/1078-0432.CCR-12-0199","article-title":"Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1\/DAB2 axis","volume":"18","author":"Tone","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"7418","key":"B27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"issue":"7353","key":"B28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"TCGA","year":"2011","journal-title":"Nature"},{"issue":"10","key":"B29","first-page":"2433","article-title":"Frequency of germline and somatic BRCA1 mutations in ovarian cancer","volume":"4","author":"Berchuck","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"16","key":"B30","first-page":"3622","article-title":"Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer","volume":"56","author":"Foster","year":"1996","journal-title":"Cancer Res"},{"issue":"4","key":"B31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ng0495-439","article-title":"Somatic mutations in the BRCA1 gene in sporadic ovarian tumours","volume":"9","author":"Merajver","year":"1995","journal-title":"Nat Genet"},{"issue":"7","key":"B32","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors","volume":"92","author":"Esteller","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"B33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ygyno.2005.10.034","article-title":"BRCA1 promoter methylation predicts adverse ovarian cancer prognosis","volume":"101","author":"Chiang","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","volume":"8","author":"Press","year":"2008","journal-title":"BMC Cancer"},{"issue":"10","key":"B35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of \u2018BRCAness\u2019 in sporadic cancers","volume":"4","author":"Turner","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"B36","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1200\/JCO.2010.28.5791","article-title":"Personalizing therapy for ovarian cancer: BRCAness and beyond","volume":"28","author":"Bast","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"B37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"4","key":"B38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"issue":"9","key":"B39","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"issue":"1","key":"B40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"issue":"3","key":"B41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/01.PGP.0000079451.72325.63","article-title":"Women harboring BRCA1\/2 germline mutations are at risk for breast and female adnexal carcinoma","volume":"22","author":"Piek","year":"2003","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"B42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ygyno.2015.06.014","article-title":"Cancer precursor lesions in the BRCA population at the time of prophylactic salpingo-oophorectomy: accuracy of assessment and potential surrogate marker for prevention","volume":"138","author":"Lheureux","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J Pathol"},{"issue":"3","key":"B44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma \u2013 evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"issue":"7","key":"B45","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/modpathol.2013.218","article-title":"Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma","volume":"27","author":"Milea","year":"2014","journal-title":"Mod Pathol"},{"issue":"1","key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"B47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"B48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"B49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7","key":"B50","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","article-title":"Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status","volume":"118","author":"Manchanda","year":"2011","journal-title":"BJOG"},{"issue":"2","key":"B51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ygyno.2013.12.009","article-title":"Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations","volume":"132","author":"Conner","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"25","key":"B52","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"B53","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"B54","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","article-title":"High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy","volume":"19","author":"Hirst","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"B55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"10","key":"B56","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","article-title":"Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature","volume":"30","author":"Carcangiu","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"B57","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ygyno.2014.07.084","article-title":"A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers","volume":"134","author":"Cass","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"B58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","article-title":"Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls","volume":"127","author":"Mingels","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"5","key":"B59","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"B60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","article-title":"Support of the \u2018fallopian tube hypothesis\u2019 in a prospective series of risk-reducing salpingo-oophorectomy specimens","volume":"49","author":"Reitsma","year":"2013","journal-title":"Eur J Cancer"},{"issue":"29","key":"B61","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from gynecologic oncology group trial GOG-0199","volume":"32","author":"Sherman","year":"2014","journal-title":"J Clin Oncol"},{"issue":"9","key":"B62","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2559.2007.02938.x","article-title":"Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective","volume":"53","author":"Jarboe","year":"2008","journal-title":"Histopathology"},{"issue":"3","key":"B64","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ygyno.2010.05.012","article-title":"Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers","volume":"118","author":"Vicus","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"2","key":"B65","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"B66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2","key":"B67","doi-asserted-by":"publisher","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"B68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1757-2215-5-13","article-title":"Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis","volume":"5","author":"Rice","year":"2012","journal-title":"J Ovarian Res"},{"issue":"1","key":"B69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"9267","key":"B70","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"B71","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"21","key":"B72","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"issue":"8","key":"B73","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"issue":"15","key":"B74","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"issue":"12","key":"B75","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/gim.2014.48","article-title":"Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations","volume":"16","author":"Garcia","year":"2014","journal-title":"Genet Med"},{"issue":"1","key":"B76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1158\/1940-6207.CAPR-15-0406","article-title":"Transforming cancer prevention through precision medicine and immune-oncology","volume":"9","author":"Kensler","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"B77","doi-asserted-by":"publisher","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"B78","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"B79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"B80","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"4","key":"B81","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses\u2019 health study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"5","key":"B82","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses\u2019 health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"B83","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3747\/co.20.1471","article-title":"Salpingectomy to prevent ovarian cancer: a countercurrents series","volume":"20","author":"Narod","year":"2013","journal-title":"Curr Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:29:00Z","timestamp":1498307340000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fonc.2016.00108\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,2]]},"references-count":83,"URL":"https:\/\/doi.org\/10.3389\/fonc.2016.00108","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,2]]}}}